Cambiar Investors LLC Exelixis, Inc. Transaction History

Cambiar Investors LLC

$2.47 Billion
Q3 2024

A detailed history of Cambiar Investors LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Cambiar Investors LLC holds 93,712 shares of EXEL stock, worth $3.34 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

93,712

Previous 93,605 0.11%

Holding current value

$3.34 Million

Previous $2.1 Million 15.6%

% of portfolio

0.1%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$21.96 - $27.6 $2,349 - $2,953	107 Added 0.11%	93,712 $2.43 Million
Q1 2024 May 02, 2024	SELL	$20.17 - $23.93 $40,178 - $47,668	-1,992 Reduced 2.08%	93,605 $2.22 Million
Q4 2023 Jan 25, 2024	SELL	$19.25 - $24.13 $554,785 - $695,426	-28,820 Reduced 23.16%	95,597 $2.29 Million
Q3 2023 Oct 30, 2023	SELL	$19.04 - $22.74 $64,926 - $77,543	-3,410 Reduced 2.67%	124,417 $2.72 Million
Q2 2023 Jul 31, 2023	SELL	$18.17 - $20.48 $246,312 - $277,626	-13,556 Reduced 9.59%	127,827 $2.44 Million
Q1 2023 May 08, 2023	SELL	$16.3 - $19.41 $7.52 Million - $8.96 Million	-461,460 Reduced 76.55%	141,383 $2.74 Million
Q4 2022 Feb 02, 2023	BUY	$14.96 - $17.39 $624,161 - $725,545	41,722 Added 7.44%	602,843 $9.67 Million
Q3 2022 Oct 28, 2022	SELL	$15.68 - $22.27 $29,352 - $41,689	-1,872 Reduced 0.33%	561,121 $8.8 Million
Q2 2022 Aug 05, 2022	SELL	$17.44 - $23.16 $423,286 - $562,116	-24,271 Reduced 4.13%	562,993 $11.7 Million
Q1 2022 Apr 28, 2022	BUY	$17.03 - $22.67 $479,275 - $638,001	28,143 Added 5.03%	587,264 $13.3 Million
Q4 2021 Jan 27, 2022	SELL	$15.84 - $21.88 $921,650 - $1.27 Million	-58,185 Reduced 9.43%	559,121 $10.2 Million
Q3 2021 Oct 22, 2021	SELL	$16.3 - $21.14 $47,905 - $62,130	-2,939 Reduced 0.47%	617,306 $13.1 Million
Q2 2021 Aug 02, 2021	BUY	$17.95 - $25.56 $2.07 Million - $2.95 Million	115,433 Added 22.87%	620,245 $11.3 Million
Q1 2021 May 14, 2021	BUY	$20.53 - $25.22 $1.22 Million - $1.5 Million	59,450 Added 13.35%	504,812 $11.4 Million
Q4 2020 Feb 03, 2021	BUY	$18.39 - $24.8 $2.15 Million - $2.9 Million	116,862 Added 35.57%	445,362 $8.94 Million
Q3 2020 Oct 21, 2020	BUY	$20.67 - $26.94 $4.83 Million - $6.3 Million	233,864 Added 247.12%	328,500 $8.03 Million
Q2 2020 Aug 03, 2020	SELL	$16.46 - $27.42 $25,233 - $42,034	-1,533 Reduced 1.59%	94,636 $2.25 Million
Q1 2020 Apr 30, 2020	BUY	$14.46 - $21.8 $1.39 Million - $2.1 Million	96,169 New	96,169 $1.66 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.

Account

Cambiar Investors LLC Exelixis, Inc. Transaction History